Companies face dramatic, unfavorable changes to the current deductibility of research and development (R&D) expenses because of a provision set to expire at the end of the year. If Congress does not intervene, taxpayers will lose the flexibility to determine when and how they account for those expenses.
Watch the recording where we discuss the approaching expiration of tax code section 174, including how you can join our efforts to bring this urgent issue to lawmakers’ attention. On this 30-minute webcast we will:
- Explain the tax ramifications in 2022 and beyond
- Walk through specific scenarios, contrasting the 174 expense method with the required capitalization method
- Examine the effects on financial statements and the R&D credit
- Update you about the discussions on Capitol Hill and what you can do to help preserve the beneficial expensing rules
